SI-BONE, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SI-BONE, INC. (SIBN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.98M, a 10.20% decline year-over-year.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $6.03M, a 9.58% decline year-over-year.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $6.23M, a 1.27% decline year-over-year.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $6.66M, a 4.06% increase year-over-year.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $25.52M, a 1.33% decline from fiscal 2024.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $25.87M, a 7.53% increase from fiscal 2023.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $24.06M, a 4.32% increase from fiscal 2022.
- SI-BONE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $23.06M, a 36.73% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.98M 10-Q · filed 2026-08-04 | $12.00M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $6.03M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $25.52M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $6.23M 10-Q · filed 2025-11-10 | $12.88M derived: sum of 2 quarters · filed 2026-08-04 | $19.55M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $6.66M 10-Q · filed 2026-08-04 | $13.32M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $6.66M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $25.87M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $6.31M 10-Q · filed 2025-11-10 | $12.70M derived: sum of 2 quarters · filed 2025-11-10 | $19.73M derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $6.40M 10-Q · filed 2025-11-10 | $13.43M derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | $7.03M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $24.06M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $5.93M 10-Q · filed 2024-11-12 | $11.93M derived: sum of 2 quarters · filed 2024-11-12 | $18.12M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $6.00M 10-Q · filed 2024-11-12 | $12.19M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $6.19M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $23.06M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $5.92M 10-Q · filed 2023-11-07 | $11.67M derived: sum of 2 quarters · filed 2023-11-07 | $17.18M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $5.75M 10-Q · filed 2023-11-07 | $11.26M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | $5.51M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $16.87M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $4.24M 10-Q · filed 2022-11-08 | $8.50M derived: sum of 2 quarters · filed 2022-11-08 | $12.53M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $4.26M 10-Q · filed 2022-11-08 | $8.29M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $4.03M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $11.93M 10-K · filed 2022-03-01 | |||
| 2020-09-30 | $3.18M 10-Q · filed 2021-11-09 | $6.13M derived: sum of 2 quarters · filed 2021-11-09 | $8.76M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $2.96M 10-Q · filed 2021-11-09 | $5.58M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $2.62M 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $7.46M 10-K · filed 2021-03-10 | |||
| 2019-09-30 | $1.91M 10-Q · filed 2020-11-03 | $3.73M derived: sum of 2 quarters · filed 2020-11-03 | $5.60M derived: sum of 3 quarters · filed 2020-11-03 | |
| 2019-06-30 | $1.81M 10-Q · filed 2020-11-03 | $3.69M derived: sum of 2 quarters · filed 2020-11-03 | ||
| 2019-03-31 | $1.87M 10-Q · filed 2020-11-03 | |||
| 2018-12-31 | $2.31M 10-K · filed 2020-03-11 | |||
| 2018-09-30 | $327.00K 10-Q · filed 2019-11-12 | $690.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.08M derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | $363.00K 10-Q · filed 2019-11-12 | $754.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | $391.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $1.44M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |